Nanoparticle-Based Drug Delivery Systems for Cardiovascular Applications
Digital Object Identifier (DOI)
Nanomedicine has vastly improved the treatment and diagnosis of many cardiovascular conditions such as atherosclerosis, myocardial ischemia, myocardial infarction, restenosis, and thrombosis. A few nanoparticle drug delivery systems that are currently being tested and used in clinical trials include lipid-based drug delivery, controlled drug release, and specific targeting. The chapter describes the various drug delivery methods, the various nanoparticles, and their application on specific cardiovascular conditions. This chapter compiles examples of specific clinical trials that are being conducted, using nanoparticles for therapy of cardiovascular conditions.
Was this content written or created while at USF?
Citation / Publisher Attribution
Nanoparticle-Based Drug Delivery Systems for Cardiovascular Applications, in A. Patel & Y. V. Pathak (Eds.), Emerging Applications, Perspectives, and Discoveries in Cardiovascular Research, IGI Global, p. 245-253
Scholar Commons Citation
Patel, Arti and Pathak, Yashwant V., "Nanoparticle-Based Drug Delivery Systems for Cardiovascular Applications" (2017). Neurology Faculty Publications. 103.